Vaxtex Cotfab Ltd. - Research Center
Group () BSE data
Results
Statement
More
Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Mar ' 20 |
Mar ' 19 |
Equity share capital
12.63 |
10.04 |
6.02 |
6.02 |
0.40 |
Share application money
Preference share capital
Reserves & surplus
10.85 |
0.32 |
2.85 |
2.63 |
4.33 |
Secured loans
5.19 |
7.45 |
10.29 |
12.62 |
3.29 |
Unsecured loans
Total
28.67 |
17.81 |
19.17 |
21.27 |
8.02 |
Gross block
Less : revaluation reserve
Less : accumulated depreciation
Net block
Capital work-in-progress
Investments
Current assets, loans & advances
64.73 |
19.04 |
17.73 |
25.44 |
11.70 |
Less : current liabilities & provisions
40.81 |
6.18 |
2.52 |
6.65 |
5.49 |
Total net current assets
23.92 |
12.86 |
15.21 |
18.78 |
6.21 |
Miscellaneous expenses not written
Total
28.67 |
17.81 |
19.17 |
21.27 |
8.02 |
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
Number of equity sharesoutstanding (Lacs)
1262.90 |
501.96 |
60.24 |
60.24 |
4.03 |